Alzheimer’s Disease (AD) is the commonest form of dementia in the elderly, characterized by memory dysfunction, loss of lexical access, spatial and temporal disorientation, and impaired judgment. A growing body of scientific literature addresses the implication of dietary habits in the pathogenesis of AD. This review reports recent findings concerning the modulation of AD development by dietary lipids, in animals and humans, focusing on the pathogenetic role of lipid oxidation products. Oxidative breakdown products of ω-6 polyunsaturated fatty acids (ω-6 PUFAs), and cholesterol oxidation products (oxysterols), might play a role in favoring β-amyloid deposition, a hallmark of AD’s onset and progression. Conversely, ω-3 PUFAs appear to contribute to preventing and treating AD. However, high concentrations of ω-3 PUFAs can also produce oxidized derivatives reacting with important functions of nervous cells. Thus, altered balances between cholesterol and oxysterols, and between ω-3 and ω-6 PUFAs must be considered in AD’s pathophysiology. The use of a diet with an appropriate ω-6/ω-3 PUFAs ratio, rich in healthy oils, fish and antioxidants, such as flavonoids, but low in cholesterol-containing foods, can be a beneficial component in the clinical strategies of prevention of AD.

Dietary lipids and their oxidized products in Alzheimer's disease.

BIASI, Fiorella;POLI, Giuseppe;LEONARDUZZI, Gabriella Marisa;Isaia G.
2011-01-01

Abstract

Alzheimer’s Disease (AD) is the commonest form of dementia in the elderly, characterized by memory dysfunction, loss of lexical access, spatial and temporal disorientation, and impaired judgment. A growing body of scientific literature addresses the implication of dietary habits in the pathogenesis of AD. This review reports recent findings concerning the modulation of AD development by dietary lipids, in animals and humans, focusing on the pathogenetic role of lipid oxidation products. Oxidative breakdown products of ω-6 polyunsaturated fatty acids (ω-6 PUFAs), and cholesterol oxidation products (oxysterols), might play a role in favoring β-amyloid deposition, a hallmark of AD’s onset and progression. Conversely, ω-3 PUFAs appear to contribute to preventing and treating AD. However, high concentrations of ω-3 PUFAs can also produce oxidized derivatives reacting with important functions of nervous cells. Thus, altered balances between cholesterol and oxysterols, and between ω-3 and ω-6 PUFAs must be considered in AD’s pathophysiology. The use of a diet with an appropriate ω-6/ω-3 PUFAs ratio, rich in healthy oils, fish and antioxidants, such as flavonoids, but low in cholesterol-containing foods, can be a beneficial component in the clinical strategies of prevention of AD.
2011
55
S161
S172
Alzheimer’s Disease; Cholesterol; Lipid oxidation products; Nutrition; PUFA
Corsinovi L; Biasi F; Poli G; Leonarduzzi G; Isaia G
File in questo prodotto:
File Dimensione Formato  
MNFR 2011.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 238.98 kB
Formato Adobe PDF
238.98 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
CORSINOVI POST PRINT con copertina.pdf

Accesso aperto

Descrizione: Review completa
Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 761.07 kB
Formato Adobe PDF
761.07 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/93503
Citazioni
  • ???jsp.display-item.citation.pmc??? 17
  • Scopus 47
  • ???jsp.display-item.citation.isi??? 40
social impact